Patent · US Active

Complex comprising a cell penetrating peptide, a cargo and a TLR peptide agonist

US12178788B2 · kind B2 · utility

0Cited by
18References
38Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 6, 2021
Grant dateDec 31, 2024
Priority date
Expiry dateAug 6, 2041

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a novel complex comprising a) a cell penetrating peptide, b) at least one antigen or antigenic epitope, and c) at least one TLR peptide agonist, wherein the components a)-c) are covalently linked. Moreover, the present invention also provides a nucleic acid encoding such a complex, wherein the complex is a peptide or a protein. Such a nucleic acid may be comprised by a vector, and such a vector may be comprised by a host cell. In particular, compositions, such as a pharmaceutical compositions and vaccines are provided, which may be useful for example in the prevention and/or treatment of a diseases and/or a disorder including cancer, hematological disorders, infectious diseases, autoimmunity disorders and transplant rejections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.